Nuvaring (Ethinylestradiol, Etonogestrel)

Ethinylestradiol, the active ingredient in Nuvaring, is a combined estrogen-progestogen contraceptive presented as a vaginal ring for vaginal use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Nuvaring as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Nuvaring is a combined hormonal contraceptive that works within the reproductive hormone pathway to prevent ovulation. - Contraception: Provides reliable, reversible prevention of pregnancy during typical use. - Menstrual cycle regulation: Helps create more predictable menstrual bleeding patterns. - Acne improvement: May reduce acne severity associated with hormonal fluctuations.

Side effects are reported by some users of Nuvaring and vary in frequency.

Common Side Effects: - Vaginal irritation or discharge - Headache - Nausea - Breast tenderness - Mood changes - Weight fluctuation

Serious or Rare Side Effects: - Deep‑vein thrombosis or pulmonary embolism - Stroke or myocardial infarction - Severe liver dysfunction - Allergic reaction with rash or swelling - Vision changes - Persistent high blood pressure

Before using Nuvaring, consider the following safety points: - Smoking: Avoid smoking, especially if over 35 years old, due to increased cardiovascular risk. - Blood pressure: Monitor blood pressure regularly, as hormonal contraceptives can elevate it. - Medical history: Discuss any history of blood clots, liver disease, or migraines with a healthcare professional. - Medication review: Inform the ​​  ...

Potential  ...